Roivant Sciences
ROIV
ROIV
314 hedge funds and large institutions have $6.65B invested in Roivant Sciences in 2024 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 93 increasing their positions, 102 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 17 → 17 (0)
9% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 102
14% less call options, than puts
Call options by funds: $9.58M | Put options by funds: $11.1M
Holders
314
Holding in Top 10
17
Calls
$9.58M
Puts
$11.1M
Top Buyers
| 1 | +$58.5M | |
| 2 | +$56.5M | |
| 3 | +$37.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$28.4M |
| 5 |
TCIM
TOMS Capital Investment Management
New York
|
+$22.1M |
Top Sellers
| 1 | -$74.4M | |
| 2 | -$48.8M | |
| 3 | -$45.9M | |
| 4 |
Goldman Sachs
New York
|
-$38.8M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$30.2M |